Similar articles

• Transdermal estradiol. A potentially improved method of hormone replacement.

  Judd HL. Judd HL. J Reprod Med. 1994 May;39(5):343-52. J Reprod Med. 1994. PMID: 8064701 Review.
• Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.

  Hemelaar M, van der Mooren MJ, Mijatovic V, Bouman AA, Schijf CP, Kroeks MV, Franke HR, Kenemans P. Hemelaar M, et al. Menopause. 2003 Nov-Dec;10(6):550-8. doi: 10.1097/01.GME.0000064866.58809.E5. Menopause. 2003. PMID: 14627865 Clinical Trial.
• A comparison of the central effects of different progestins used in hormone replacement therapy.

  Cagnacci A, Arangino S, Baldassari F, Alessandrini C, Landi S, Volpe A. Cagnacci A, et al. Maturitas. 2004 Aug 20;48(4):456-62. doi: 10.1016/j.maturitas.2003.10.003. Maturitas. 2004. PMID: 15283939 Clinical Trial.
• Transdermal estradiol reduces F2alpha-isoprostane levels in postmenopausal women.

  Hermenegildo C, Oviedo PJ, Laguna A, García-Pérez MA, Tarín JJ, Cano A. Hermenegildo C, et al. Menopause. 2008 Jul-Aug;15(4 Pt 1):714-7. doi: 10.1097/gme.0b013e31815f8943. Menopause. 2008. PMID: 18340278 Clinical Trial.
• Postmenopausal hormone replacement therapy and insulin metabolism: effects of route of administration and implications for heart disease and diabetes risk.

  Godsland IF, Stevenson JC. Godsland IF, et al. Br J Clin Pract Suppl. 1996 Sep;86:1-5. Br J Clin Pract Suppl. 1996. PMID: 8995002 Review. No abstract available.